e-learning
resources
Barcelona 2010
Monday, 20.09.2010
COPD and asthma: models and human studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Caspase-1 pathway in COPD
P. Sobradillo, R. Faner, A. Agustí, E. Ballester, N. Soler, J. Yagüe, M. Juan, J. I. Aróstegui (Barcelona, Spain)
Source:
Annual Congress 2010 - COPD and asthma: models and human studies
Session:
COPD and asthma: models and human studies
Session type:
E-Communication Session
Number:
1999
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Sobradillo, R. Faner, A. Agustí, E. Ballester, N. Soler, J. Yagüe, M. Juan, J. I. Aróstegui (Barcelona, Spain). Caspase-1 pathway in COPD. Eur Respir J 2010; 36: Suppl. 54, 1999
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Activation of the inflammasome pathway during exacerbations of COPD
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
Activation of IL-32 pathway in COPD
Source: Annual Congress 2008 - Cell biology of asthma and COPD
Year: 2008
The activation of NLRP3 inflammasome pathway in COPD is limited in local airways
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
Andrographolide inhibits the activation of NLRP3 inflammasome in patients with COPD
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018
NLRP3 inflammasome is activated via phosphoinositide 3-kinase δ pathway in Aspergillus fumigatus-induced allergic airway inflammation
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
In addition to mTOR and JAK/STAT, NLRP3 inflammasome is another key pathway activated in sarcoidosis
Source: Eur Respir J, 55 (3) 2000149; 10.1183/13993003.00149-2020
Year: 2020
The inflammasome pathway in stable COPD and acute exacerbations
Source: ERJ Open Res 2016: 00002-2016
Year: 2016
A role for the inflammasome effector caspase-1 in hypoxia-induced pulmonary hypertension
Source: International Congress 2017 – Experimental PH
Year: 2017
Hedgehog pathway activation is altered in COPD patients
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Analysis of cytokine signaling pathway JAK-STAT through their activation in patients with asthma
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
Notch pathway signaling in asthma
Source: Annual Congress 2006 - Markers of paediatric airway disease
Year: 2006
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Cigarette smoke extract inhibits the NLRP3 inflammasome in human macrophages and impairs cell metabolism via NLRP3-independent activation of Caspase-1
Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms
Year: 2019
Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
Role of the kinase-dependent functions of RIPK1 in COPD
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Elevated expression of the NLRP3 inflammasome in neutrophilic asthma
Source: Eur Respir J 2014; 43: 1067-1076
Year: 2014
Statins worse pulmonary fibrosis through enhancing NLRP3 inflammasome activation
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation
Source: Eur Respir J, 55 (3) 1900119; 10.1183/13993003.00119-2019
Year: 2020
Role of necroptosis in the pathogenesis of COPD
Source: International Congress 2019 – Mechanisms underlying acute exacerbation of respiratory disease
Year: 2019
The NLRP3 inflammasome in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept